Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

Similar articles for PubMed (Select 24045604)

1.

Acute treatment of trigeminal neuralgia with onabotulinum toxin A.

Zúñiga C, Piedimonte F, Díaz S, Micheli F.

Clin Neuropharmacol. 2013 Sep-Oct;36(5):146-50. doi: 10.1097/WNF.0b013e31829cb60e.

PMID:
24045604
2.

Botulinum toxin type A for the treatment of trigeminal neuralgia: results from a randomized, double-blind, placebo-controlled trial.

Wu CJ, Lian YJ, Zheng YK, Zhang HF, Chen Y, Xie NC, Wang LJ.

Cephalalgia. 2012 Apr;32(6):443-50. doi: 10.1177/0333102412441721. Epub 2012 Apr 5.

PMID:
22492424
3.

Therapeutic effect of Botulinum toxin-A in 88 patients with trigeminal neuralgia with 14-month follow-up.

Li S, Lian YJ, Chen Y, Zhang HF, Ma YQ, He CH, Wu CJ, Xie NC, Zheng YK, Zhang Y.

J Headache Pain. 2014 Jun 22;15:43. doi: 10.1186/1129-2377-15-43.

4.

Botulinum toxin-type A: could it be an effective treatment option in intractable trigeminal neuralgia?

Shehata HS, El-Tamawy MS, Shalaby NM, Ramzy G.

J Headache Pain. 2013 Nov 19;14:92. doi: 10.1186/1129-2377-14-92.

5.

Therapeutic efficacy and safety of botulinum toxin type A in trigeminal neuralgia: a systematic review.

Hu Y, Guan X, Fan L, Li M, Liao Y, Nie Z, Jin L.

J Headache Pain. 2013 Aug 21;14:72. doi: 10.1186/1129-2377-14-72. Review.

7.

Botulinum toxin A in postherpetic neuralgia: a parallel, randomized, double-blind, single-dose, placebo-controlled trial.

Apalla Z, Sotiriou E, Lallas A, Lazaridou E, Ioannides D.

Clin J Pain. 2013 Oct;29(10):857-64. doi: 10.1097/AJP.0b013e31827a72d2.

PMID:
23370074
8.

Botulinum toxin type-A in the prophylactic treatment of medication-overuse headache: a multicenter, double-blind, randomized, placebo-controlled, parallel group study.

Sandrini G, Perrotta A, Tassorelli C, Torelli P, Brighina F, Sances G, Nappi G.

J Headache Pain. 2011 Aug;12(4):427-33. doi: 10.1007/s10194-011-0339-z. Epub 2011 Apr 16.

9.

Dilution of botulinum toxin A in lidocaine vs. in normal saline for the treatment of primary axillary hyperhidrosis: a double-blind, randomized, comparative preliminary study.

Güleç AT.

J Eur Acad Dermatol Venereol. 2012 Mar;26(3):314-8. doi: 10.1111/j.1468-3083.2011.04066.x. Epub 2011 Apr 15.

PMID:
21492253
10.

A pilot study of botulinum toxin A for male chronic pelvic pain syndrome.

Gottsch HP, Yang CC, Berger RE.

Scand J Urol Nephrol. 2011 Feb;45(1):72-6. doi: 10.3109/00365599.2010.529820. Epub 2010 Nov 9.

PMID:
21062115
11.

Botulinum toxin injection for management of thoracic outlet syndrome: a double-blind, randomized, controlled trial.

Finlayson HC, O'Connor RJ, Brasher PM, Travlos A.

Pain. 2011 Sep;152(9):2023-8. doi: 10.1016/j.pain.2011.04.027. Epub 2011 May 31.

PMID:
21628084
12.

A pilot study of botulinum toxin for interstitial cystitis/painful bladder syndrome.

Gottsch HP, Miller JL, Yang CC, Berger RE.

Neurourol Urodyn. 2011 Jan;30(1):93-6. doi: 10.1002/nau.20946. Epub 2010 Jun 29.

PMID:
20589903
13.

Use of botulinum toxin A for drug-refractory trigeminal neuralgia: preliminary report.

Bohluli B, Motamedi MH, Bagheri SC, Bayat M, Lassemi E, Navi F, Moharamnejad N.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011 Jan;111(1):47-50. doi: 10.1016/j.tripleo.2010.04.043. Epub 2010 Jul 31.

PMID:
20674409
14.

Efficacy of botulinum toxin type A for treatment of persistent myofascial TMD pain: a randomized, controlled, double-blind multicenter study.

Ernberg M, Hedenberg-Magnusson B, List T, Svensson P.

Pain. 2011 Sep;152(9):1988-96. doi: 10.1016/j.pain.2011.03.036. Epub 2011 Apr 22.

PMID:
21514731
15.
16.

A new treatment paradigm for trigeminal neuralgia using Botulinum toxin type A.

Guardiani E, Sadoughi B, Blitzer A, Sirois D.

Laryngoscope. 2014 Feb;124(2):413-7. doi: 10.1002/lary.24286. Epub 2013 Aug 5. Review.

PMID:
23818108
17.

The effect of single-application topical ophthalmic anesthesia in patients with trigeminal neuralgia. A randomized double-blind placebo-controlled trial.

Kondziolka D, Lemley T, Kestle JR, Lunsford LD, Fromm GH, Jannetta PJ.

J Neurosurg. 1994 Jun;80(6):993-7.

PMID:
8189280
18.

Effect of electrical stimulation on botulinum toxin a therapy in patients with chronic myofascial pain syndrome: a 16-week randomized double-blinded study.

Seo HG, Bang MS, Chung SG, Jung SH, Lee SU.

Arch Phys Med Rehabil. 2013 Mar;94(3):412-8. doi: 10.1016/j.apmr.2012.09.034. Epub 2012 Nov 1.

PMID:
23123438
19.

Intranasal lidocaine 8% spray for second-division trigeminal neuralgia.

Kanai A, Suzuki A, Kobayashi M, Hoka S.

Br J Anaesth. 2006 Oct;97(4):559-63. Epub 2006 Aug 1.

20.

Injections of botulinum toxin type a produce pain alleviation in intractable trigeminal neuralgia.

Allam N, Brasil-Neto JP, Brown G, Tomaz C.

Clin J Pain. 2005 Mar-Apr;21(2):182-4.

PMID:
15722812
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk